Lactation duration and lifetime progression to metabolic syndrome in women according to their history of gestational diabetes: a prospective longitudinal community-based cohort study.
Gestational diabetes mellitus
Hypertension
Insulin resistance
Lactation
Metabolic syndrome
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
06 03 2023
06 03 2023
Historique:
received:
05
12
2022
accepted:
16
02
2023
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
9
3
2023
Statut:
epublish
Résumé
Despite the many signs of progress in pharmacotherapies, metabolic syndrome (MetS) is one of the main public-health burdens worldwide. Our study aimed to compare the effect of breastfeeding (BF) in women with and without gestational diabetes mellitus (GDM) on MetS incidence. Of females who participated in the Tehran Lipid and glucose study, women who met our inclusion criteria were selected. The Cox proportional hazards regression model, with adjustment of potential confounders, was done to evaluate the relationship between duration of BF and incident of MetS in women with a GDM history compared to non-GDM. Out of 1176 women, there were 1001 non-GDM and 175 GDM. The median follow-up was 16.3 (11.9, 19.3) years. Results of the adjusted model illustrated that the total BF duration was negatively associated with MetS incidence risk (hazard ratio (HR) 0.98, 95% CI 0.98-0.99) in total participants indicating that per one-month increase of BF duration, the hazard of MetS reduced by 2%. The HR of MetS in Comparison between GDM and non-GDM women demonstrated significantly more reduced MetS incidence with a longer duration of exclusive BF (HR 0.93, 95% CI 0.88-0.98). Our findings illustrated the protective effect of BF, especially exclusive BF, on MetS incidence risk. BF is more effective in reducing the risk of MetS among women with a history of GDM than among women without such a history.
Sections du résumé
BACKGROUND
Despite the many signs of progress in pharmacotherapies, metabolic syndrome (MetS) is one of the main public-health burdens worldwide. Our study aimed to compare the effect of breastfeeding (BF) in women with and without gestational diabetes mellitus (GDM) on MetS incidence.
METHODS
Of females who participated in the Tehran Lipid and glucose study, women who met our inclusion criteria were selected. The Cox proportional hazards regression model, with adjustment of potential confounders, was done to evaluate the relationship between duration of BF and incident of MetS in women with a GDM history compared to non-GDM.
RESULTS
Out of 1176 women, there were 1001 non-GDM and 175 GDM. The median follow-up was 16.3 (11.9, 19.3) years. Results of the adjusted model illustrated that the total BF duration was negatively associated with MetS incidence risk (hazard ratio (HR) 0.98, 95% CI 0.98-0.99) in total participants indicating that per one-month increase of BF duration, the hazard of MetS reduced by 2%. The HR of MetS in Comparison between GDM and non-GDM women demonstrated significantly more reduced MetS incidence with a longer duration of exclusive BF (HR 0.93, 95% CI 0.88-0.98).
CONCLUSIONS
Our findings illustrated the protective effect of BF, especially exclusive BF, on MetS incidence risk. BF is more effective in reducing the risk of MetS among women with a history of GDM than among women without such a history.
Identifiants
pubmed: 36879241
doi: 10.1186/s12967-023-04005-w
pii: 10.1186/s12967-023-04005-w
pmc: PMC9987076
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
177Informations de copyright
© 2023. The Author(s).
Références
Horm Behav. 2011 Feb;59(2):202-12
pubmed: 21094649
Diabetes Res Clin Pract. 2015 Oct;110(1):10-17
pubmed: 26278351
Am J Clin Nutr. 1993 Aug;58(2):162-6
pubmed: 8338042
Am J Clin Nutr. 1999 Feb;69(2):299-307
pubmed: 9989696
Endocrinology. 2002 Apr;143(4):1378-85
pubmed: 11897695
Diabetes Care. 2016 Jul;39(7):1250-8
pubmed: 27208323
Diabetes Metab Res Rev. 2011 Sep;27(6):564-74
pubmed: 21557442
Int J MCH AIDS. 2015;3(1):16-21
pubmed: 27621982
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
J Alzheimers Dis. 2013;37(4):809-21
pubmed: 23948914
Asia Pac J Public Health. 2019 Apr;31(3):183-198
pubmed: 30832484
Curr Opin Pharmacol. 2004 Dec;4(6):583-8
pubmed: 15525548
Diabetes Care. 2016 Jan;39 Suppl 1:S13-22
pubmed: 26696675
J Rheumatol. 2015 Sep;42(9):1563-9
pubmed: 26178286
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2052-9
pubmed: 22895666
Science. 2007 Nov 2;318(5851):806-9
pubmed: 17975067
Int J Mol Sci. 2021 Nov 02;22(21):
pubmed: 34769303
Nutr Metab Cardiovasc Dis. 2007 Feb;17(2):125-39
pubmed: 17270403
Arch Dis Child. 2003 Sep;88(9):778-83
pubmed: 12937095
Med Sci Sports Exerc. 1993 Jan;25(1):92-8
pubmed: 8423761
Metabolism. 2015 Jan;64(1):131-45
pubmed: 25497344
J Womens Health (Larchmt). 2017 Apr;26(4):361-367
pubmed: 28072915
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):975-82
pubmed: 25979970
Medicine (Baltimore). 2020 Apr;99(16):e19643
pubmed: 32311936
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Ann Intern Med. 2015 Dec 15;163(12):889-98
pubmed: 26595611
Neuropeptides. 2012 Dec;46(6):261-74
pubmed: 22979996
Diabetes. 2011 Apr;60(4):1277-85
pubmed: 21350085
Nutrients. 2018 Jul 21;10(7):
pubmed: 30037073
Infant Behav Dev. 2015 Aug;40:252-8
pubmed: 26196472
Obstet Gynecol. 2015 Aug;126(2):381-390
pubmed: 26241429
Am J Clin Nutr. 2014 Jan;99(1):115-21
pubmed: 24196401
Metabolism. 2019 Jun;95:36-45
pubmed: 30905634
Perspect Public Health. 2017 Nov;137(6):307-308
pubmed: 29082842
Breastfeed Med. 2013 Feb;8(1):8-15
pubmed: 23057641
Arch Iran Med. 2010 May;13(3):243-4
pubmed: 20433230
Am J Clin Nutr. 1989 Feb;49(2):259-65
pubmed: 2916446
Int J Endocrinol Metab. 2018 Oct 22;16(4 Suppl):e84777
pubmed: 30584442
Ann Med. 2008;40(6):465-73
pubmed: 19160571
Breastfeed Med. 2015 Apr;10(3):163-7
pubmed: 25785993
Lancet. 2016 Jan 30;387(10017):475-90
pubmed: 26869575
Nutrients. 2020 Sep 05;12(9):
pubmed: 32899507
Matern Child Health J. 2012 Feb;16(2):316-21
pubmed: 21404071
Annu Rev Nutr. 1997;17:19-36
pubmed: 9240917
Rev Bras Ginecol Obstet. 2018 Jun;40(6):354-359
pubmed: 29980160
Ann N Y Acad Sci. 2010 Nov;1212:E1-E19
pubmed: 21276002
J Clin Endocrinol Metab. 1995 Oct;80(10):2954-9
pubmed: 7559880
Public Health Nutr. 2010 Dec;13(12):2019-26
pubmed: 20519049
Diabetes Metab Res Rev. 2017 May;33(4):
pubmed: 28072911
Arch Iran Med. 2012 May;15(5):279-82
pubmed: 22519376
Int J Womens Health. 2012;4:333-9
pubmed: 22870047
JAMA Intern Med. 2018 Mar 1;178(3):328-337
pubmed: 29340577
Lancet. 2005 Apr 16-22;365(9468):1415-28
pubmed: 15836891
J Nutr. 1998 Feb;128(2 Suppl):381S-385S
pubmed: 9478031
Diabet Med. 2013 Sep;30(9):1094-101
pubmed: 23692476
Int J Obes (Lond). 2017 Jun;41(6):878-886
pubmed: 28138133
Biochem Biophys Res Commun. 2011 Sep 30;413(3):454-9
pubmed: 21907183
Am J Clin Nutr. 1995 Feb;61(2):287-95
pubmed: 7840065
Am J Clin Nutr. 1988 Jul;48(1):44-9
pubmed: 3389329
Horm Metab Res. 2011 Aug;43(9):593-600
pubmed: 21823053
Diabetes. 2010 Feb;59(2):495-504
pubmed: 19959762